Edition:
India

Allakos Inc (ALLK.OQ)

ALLK.OQ on NASDAQ Stock Exchange Global Select Market

80.28USD
25 Sep 2020
Change (% chg)

-- (--)
Prev Close
$80.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
106,043
52-wk High
$139.89
52-wk Low
$42.33

Latest Key Developments (Source: Significant Developments)

Allakos Reports Q2 Loss Per Share Of $0.80
Monday, 10 Aug 2020 

Aug 10 (Reuters) - Allakos Inc ::ALLAKOS REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q2 LOSS PER SHARE $0.80.Q2 EARNINGS PER SHARE ESTIMATE $-0.61 -- REFINITIV IBES DATA.ENDED Q2 WITH $454.9 MILLION IN CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES.  Full Article

Allakos Inc Files For Offering $200 Million Of Shares Of Common Stock
Tuesday, 6 Aug 2019 

Aug 5 (Reuters) - Allakos Inc ::ALLAKOS INC FILES FOR OFFERING $200 MILLION OF SHARES OF COMMON STOCK - SEC FILING.  Full Article

Allakos Q4 Earnings Per Share Estimate $-0.31 -- Refinitiv IBES Data
Friday, 15 Mar 2019 

March 14 (Reuters) - Allakos Inc ::ALLAKOS REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS AND 2018 CORPORATE HIGHLIGHTS.Q4 LOSS PER SHARE $0.35.Q4 EARNINGS PER SHARE ESTIMATE $-0.31 -- REFINITIV IBES DATA.ENDED FISCAL YEAR 2018 WITH $178.9 MILLION IN CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES.  Full Article

Allakos Q3 Loss Per Share $0.34
Friday, 9 Nov 2018 

Nov 8 (Reuters) - Allakos Inc ::ALLAKOS ANNOUNCES CLINICAL UPDATE AND THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.34.Q3 EARNINGS PER SHARE VIEW $-0.24 -- THOMSON REUTERS I/B/E/S.ENDED QUARTER WITH $193.5 MILLION IN CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES.  Full Article

BRIEF-Allakos Initiates Patient Recruitment For AK002 Registrational Studies

* ALLAKOS INITIATES PATIENT RECRUITMENT FOR AK002 REGISTRATIONAL STUDIES